N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide
C24H27BrN6O2S — CID 90939764
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide
N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide (PubChem CID 90939764) has the molecular formula C24H27BrN6O2S and a molecular weight of 543.49 g/mol. Its IUPAC name is N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide |
|---|---|
| PubChem CID | 90939764 |
| Molecular Formula | C24H27BrN6O2S |
| Molecular Weight | 543.49 g/mol |
| Exact Mass | 542.11 |
| IUPAC Name | N-[[1-(6-bromo-7-ethyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide |
| SMILES | CCc1c(Br)c(N2CCC(CNS(C)(=O)=O)CC2)nc2c(-c3cnc4ccccc4c3)cnn12 |
| InChI | InChI=1S/C24H27BrN6O2S/c1-3-21-22(25)24(30-10-8-16(9-11-30)13-28-34(2,32)33)29-23-19(15-27-31(21)23)18-12-17-6-4-5-7-20(17)26-14-18/h4-7,12,14-16,28H,3,8-11,13H2,1-2H3 |
| InChIKey | NIDYDJWEKHKSJB-UHFFFAOYSA-N |
| XLogP | 4.03 |
| TPSA | 92.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 543.49 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90939764 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.